Showing results (1151-1160 of 1,298) with videos related to

Sort By:
Pageof 130
Environmental Health Perspectives|November 6, 2018
Long-Term Exposure to Ambient Fine Particulate Matter and Chronic Kidney Disease: A Cohort StudyTa-Chien Chan, Zilong Zhang, Bo-Cheng Lin, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 1, 2020
Effectiveness of non-pharmaceutical interventions on COVID-19 transmission in 190 countries from 23 January to 13 April 2020Yacong Bo, Cui Guo, Changqing Lin, et al.
Heart, Lung & Circulation|November 2, 2020
Predictors of Anticoagulation Use in Indigenous and Non-Indigenous Australians With Atrial FibrillationSimon Rocheleau, Celine Gallagher, Bradley M Pitman, et al.
Frontiers in Physiology|December 16, 2021
A Role for Adipocytes and Adipose Stem Cells in the Breast Tumor Microenvironment and Regenerative MedicineCourtney K Brock, Katherine L Hebert, Maria Artiles, et al.
International Journal of Cardiology|May 13, 2015
Underuse and overuse of anticoagulation for atrial fibrillation: A study in Indigenous and non-Indigenous AustraliansChristopher X Wong, Sarah W Lee, Siang Wei Gan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollmentP N Lara, R Higdon, N Lim, et al.
The Canadian Journal of Cardiology|October 13, 2019
Self-Reported Daytime Sleepiness and Sleep-Disordered Breathing in Patients With Atrial Fibrillation: SNOozE-AFKadhim Kadhim, Melissa E Middeldorp, Adrian D Elliott, et al.
International Journal of Epidemiology|May 26, 2017
Satellite-based estimates of long-term exposure to fine particulate matter are associated with C-reactive protein in 30 034 Taiwanese adultsZilong Zhang, Ly-Yun Chang, Alexis K H Lau, et al.
BMJ Open|August 10, 2021
Rationale and design of the IRON-AF study: a double-blind, randomised, placebo-controlled study to assess the effect of intravenous ferric carboxymaltose in patients with atrial fibrillation and iron deficiencySamuel J Tu, Adrian D Elliott, Nicole Hanna-Rivero, et al.
Cancer Chemotherapy and Pharmacology|August 8, 2001
Activity of high-dose toremifene plus cisplatin in platinum-treated non-small-cell lung cancer: a phase II California Cancer Consortium TrialP N Lara, D R Gandara, J Longmate, et al.
Pageof 130